Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery
Authors:
- Jia-Ling HuangJHJia-Ling Huang
- Qi-Cai LiuQLQi-Cai Liu
- Pei-Hong WuPWPei-Hong Wu
- Ran-Yi LiuRLRan-Yi Liu
- Yi-Xin ZengYZYi-Xin Zeng
- Wen-Lin HuangWHWen-Lin Huang
Open Access
- 1 January 2004
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 10 (13) , 1867-1871
Abstract
Endostatin gene therapy for liver cancer by a recombinant adenovirus deliveryKeywords
This publication has 32 references indexed in Scilit:
- Repeated Intravesical Instillations of an Adenoviral Vector in Patients With Locally Advanced Bladder Cancer: A Phase I Study of p53 Gene TherapyJournal of Clinical Oncology, 2003
- Unusual Properties of Adenovirus E2E Transcription by RNA Polymerase IIIJournal of Virology, 2003
- Intravascular adenoviral agents in cancer patients: Lessons from clinical trialsCancer Gene Therapy, 2002
- Adeno-associated virus–mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivoCancer Gene Therapy, 2002
- Intratumoral Administration of Low Doses of an Adenovirus Vector Encoding Tumor Necrosis Factor α Together with Naive Dendritic Cells Elicits Significant Suppression of Tumor Growth without ToxicityHuman Gene Therapy, 2001
- Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolizationHistopathology, 2001
- Longitudinal Follow-up of Cellular and Humoral Immunity Induced by Recombinant Adenovirus-Mediated Gene Therapy in Cancer PatientsHuman Gene Therapy, 2000
- Effective repeat administration with adenovirus vectors to the muscleGene Therapy, 2000
- Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in MiceScience, 1999
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI: Journal of the National Cancer Institute, 1990